A major advance in immunology has been the demonstration that recognition of certain self determinants is required for both the initiation and subsequent expression of immunity (reviewed in 1). For example, in order for T cells to be activated by soluble antigens, they must recognize antigenic deter
The autologous mixed lymphocyte reaction in systemic lupus erythematosus
β Scribed by Patrick J. Riccardi; Perrie B. Hausman; Howard V. Raff; John D. Stobo
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 413 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
The autologous mixed lymphocyte r e a c t i o n (AMLR) r e p r e s e n t s t h e p r o l i f e r a t i o n o f T c e l l s i n response t o s i g n a l s from autologous non-T c e l Is. F r a c t i o n a t i o n o f t h e non-T p o p u l a t i o n i n t o B e n r i c h e d and macrophage e n r i c h e d c e l l s demonstrated t h a t b o t h c o u l d serve as e f f e c t i v e s t i m u l a t o r c e l l s i n t h e AMLR. C y t o l y t i c t r e a t m e n t o f b o t h p o p u l a t i o n s w i t h a macrophage s p e c if i c , monoclonal a n t i b o d y abrogated s t i m u l a t i o n o f t h e macrophage b u t n o t t h e B c e l l p o p u l a t i o n . U t i l i z i n g a s e r i e s o f n e g a t i v e s e l e c t i o n proceduresc y t o l y s i s w i t h T c e l l s p e c i f i c monoclonal a n t i b o d y , m e t a b o l i c s u i c i d e with 5-bromo-2-deoxyuridine (brdU) and l i g h ti t c o u l d be demonstrated t h a t T c e l l s responding t o autologous macrophage were d i s t i n c t from t h o s e respons i v e t o autologous B c e l l s .
S t u d i e s o f t h e AMLR react i v i t y t o B c e l l s and macrophage i n a small number of p a t i e n t s w i t h a c t i v e systemic l u p u s erythematosus (SLE) demonstrated t h a t a l t h o u g h r e a c t i v i t y t o b o t h populat i o n s was diminished, t h e response t o autologous B c e l l s was reduced more t h a n t h e response t o a u t o l o g o u s macrophage.
π SIMILAR VOLUMES
## Abstract ## Objective To gain preliminary evidence for the safety and efficacy of B lymphocyte depletion therapy in refractory systemic lupus erythematosus (SLE). ## Methods Six female patients with active SLE, resistant to standard immunosuppressive therapy, were treated on an openβlabel bas